Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04968379
What this trial is testing

Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia

Who this might be right for
Iron Deficiency, Anaemia
American Regent, Inc.
Testing effectiveness (Phase 2)Study completedNCT01899703
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus

Who this might be right for
Cholestasis, Intrahepatic
GlaxoSmithKline 22
Very early researchStudy completedNCT05552274
What this trial is testing

FTIH of ECC4703 in Healthy Volunteers

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Eccogene 75
Early research (Phase 1)Study completedNCT04978688
What this trial is testing

Study of Relugolix Alone and Relugolix Combined With Hormonal Add-Back Therapy in Healthy Premenopausal Female Participants

Who this might be right for
Healthy
Myovant Sciences GmbH 48
Early research (Phase 1)Study completedNCT05028556
What this trial is testing

A Trial of Y101D, a PD-L1/TGF-β Bispecific Antibody, in Patients With Metastatic or Locally Advanced Solid Tumors

Who this might be right for
Metastatic or Locally Advanced Solid Tumors
Wuhan YZY Biopharma Co., Ltd. 50
Early research (Phase 1)Study completedNCT02914353
What this trial is testing

Study to Evaluate Safety, PK and PD of Single and Multiple Ascending Doses of EP-7041 in Healthy Subjects

Who this might be right for
Arthroplasty, Replacement, Knee
eXIthera Pharmaceuticals 80
Testing effectiveness (Phase 2)Study completedNCT05324137
What this trial is testing

CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps

Who this might be right for
Chronic Rhinosinusitis With Nasal Polyps
Keymed Biosciences Co.Ltd 88
Large-scale testing (Phase 3)Study completedNCT01072149
What this trial is testing

Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to Placebo

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 54
Early research (Phase 1)Looking for participantsNCT07800936
What this trial is testing

HP007 Monotherapy for Relapsed or Refractory Advanced Solid Tumors

Who this might be right for
Solid Tumors
Parr Biotechnology (Hebei) Co., Ltd. 44
Early research (Phase 1)Study completedNCT01208753
What this trial is testing

Pharmacokinetics/Pharmacodynamics (PK/PD) of Multiple Oral Doses of GLPG0555 in Healthy Subjects

Who this might be right for
Healthy
Lakefront Biotherapeutics NV 24
Testing effectiveness (Phase 2)Study completedNCT04641299
What this trial is testing

AZD8233 in Participants With Dyslipidemia

Who this might be right for
Dyslipidaemia
AstraZeneca 119
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747416
What this trial is testing

KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors

Who this might be right for
Hemophilia a and B
Suzhou Alphamab Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT01889667
What this trial is testing

Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes Mellitus Type 2
Oramed, Ltd. 30
Early research (Phase 1)Study completedNCT06204809
What this trial is testing

Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
PepGen Inc 24
Early research (Phase 1)Study completedNCT02004587
What this trial is testing

Influence of Hepatic Impairment on Pharmacokinetic (PK) and Pharmacodynamic (PD) of Gemigliptin PK and PD After Multiple Oral Doses in Healthy White Volunteers

Who this might be right for
Hepatic Impairment
LG Life Sciences 28
Early research (Phase 1)Study completedNCT02306915
What this trial is testing

PK, PD, Safety and Tolerability of Lipegfilgrastim in Healthy Japanese and Caucasian Participants

Who this might be right for
PharmacokineticsPharmacodynamics
Merckle GmbH 48
Early research (Phase 1)Study completedNCT04464733
What this trial is testing

Safety, Tolerability, Pharmacokinetics(PK), Pharmacodynamics(PD) and Food Effect of HRS9950 in Healthy and CHB Subjects

Who this might be right for
Chronic Hepatitis b
Jiangsu HengRui Medicine Co., Ltd. 146
Early research (Phase 1)Study completedNCT03579030
What this trial is testing

Safety and PK/PD of RTA 1701 in Healthy Adults

Who this might be right for
Healthy
Biogen 90
Early research (Phase 1)Study completedNCT03870100
What this trial is testing

The PK/PD Study of A Single Subcutaneous Injection of SHR-1222 in Healthy Subjects

Who this might be right for
Osteoporosis
Jiangsu HengRui Medicine Co., Ltd. 50
Early research (Phase 1)Looking for participantsNCT05522868
What this trial is testing

SB17170 Phase 1 Clinical Trial in Solid Tumors

Who this might be right for
Solid Tumor
SPARK Biopharma 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation